Impact of multicomponent, nonpharmacological care program for mild Alzheimer’s disease with anxiety and depression

BACKGROUND Patients with mild Alzheimer’s disease (AD) frequently suffer from comorbid anxiety and depression, which exacerbate neuropsychiatric symptoms, reduce quality of life, and increase caregiver burden. Conventional pharmacological treatments often inadequately address these multifaceted issues. AIM To evaluate the impact of a multicomponent, nonpharmacological care program on the neuropsychiatric symptoms, quality of life, caregiver burden, cognitive function, and sleep quality in patients with mild AD experiencing comorbid anxiety and depression. METHODS A retrospective analysis was conducted on 200 individuals diagnosed with mild AD and exhibited symptoms of anxiety and depression [Geriatric Anxiety Inventory-Short Form (GAI-SF) ≥ 3; Geriatric Depression Scale-15 (GDS-15) ≥ 6]. The patients received either conventional care (donepezil 5 mg/day plus basic health education, n = 104) or a multicomponent, nonpharmacological care program (additional 24 sessions over 12 weeks including cognitive rehabilitation, occupational therapy, art/doll therapy, exercise training, and speech therapy, n = 96). Evaluations were conducted at baseline and following a 3-month period using the Neuropsychiatric Inventory (NPI), GAI-SF, GDS-15, AD Cooperative Study Activities of Daily Living (ADCS-ADL), Quality of Life-AD (QOL-AD), Zarit Caregiver Burden Interview (ZBI), Mini-Mental State Examination (MMSE), AD Assessment Scale-Cognitive Subscale (ADAS-cog), and Pittsburgh Sleep Quality Index (PSQI). RESULTS At 3 months, the multicomponent group showed the following markedly superior outcomes than the conventional group: Lower NPI total symptom score (P = 0.004) and caregiver distress (P = 0.020); Lower GAI-SF (P = 0.003) and GDS-15 (P = 0.003); Higher ADCS-ADL (P < 0.001) and QOL-AD (P < 0.001); Lower ZBI (P = 0.004); Higher MMSE (P = 0.004) and lower ADAS-cog (P = 0.024); and lower PSQI (P < 0.001). CONCLUSION The multicomponent, nonpharmacological care program is associated with improved neuropsychiatric symptoms, anxiety, depression, quality of life, caregiver burden, cognitive function, and sleep quality in patients with mild AD experiencing anxiety and depression.

Authors

Publication Details

Journal
World Journal of Psychiatry
Published
2026-11-19
DOI
https://doi.org/10.5498/wjp.123323
Primary Topic
Dementia and Cognitive Impairment Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Impact of multicomponent, nonpharmacological care program for mild Alzheimer’s disease with anxiety and depression

Chen Ya-fei, Yan Zhu, Jin-Na Zhang, Bi-Xia Li
1 links
World Journal of Psychiatry
Dementia and Cognitive Impairment Research
article

Impact of multicomponent, nonpharmacological care program for mild Alzheimer’s disease with anxiety and depression

Chen Ya-fei, Yan Zhu, Jin-Na Zhang, Bi-Xia Li
article en

Abstract

BACKGROUND Patients with mild Alzheimer’s disease (AD) frequently suffer from comorbid anxiety and depression, which exacerbate neuropsychiatric symptoms, reduce quality of life, and increase caregiver burden. Conventional pharmacological treatments often inadequately address these multifaceted issues. AIM To evaluate the impact of a multicomponent, nonpharmacological care program on the neuropsychiatric symptoms, quality of life, caregiver burden, cognitive function, and sleep quality in patients with mild AD experiencing comorbid anxiety and depression. METHODS A retrospective analysis was conducted on 200 individuals diagnosed with mild AD and exhibited symptoms of anxiety and depression [Geriatric Anxiety Inventory-Short Form (GAI-SF) ≥ 3; Geriatric Depression Scale-15 (GDS-15) ≥ 6]. The patients received either conventional care (donepezil 5 mg/day plus basic health education, n = 104) or a multicomponent, nonpharmacological care program (additional 24 sessions over 12 weeks including cognitive rehabilitation, occupational therapy, art/doll therapy, exercise training, and speech therapy, n = 96). Evaluations were conducted at baseline and following a 3-month period using the Neuropsychiatric Inventory (NPI), GAI-SF, GDS-15, AD Cooperative Study Activities of Daily Living (ADCS-ADL), Quality of Life-AD (QOL-AD), Zarit Caregiver Burden Interview (ZBI), Mini-Mental State Examination (MMSE), AD Assessment Scale-Cognitive Subscale (ADAS-cog), and Pittsburgh Sleep Quality Index (PSQI). RESULTS At 3 months, the multicomponent group showed the following markedly superior outcomes than the conventional group: Lower NPI total symptom score (P = 0.004) and caregiver distress (P = 0.020); Lower GAI-SF (P = 0.003) and GDS-15 (P = 0.003); Higher ADCS-ADL (P < 0.001) and QOL-AD (P < 0.001); Lower ZBI (P = 0.004); Higher MMSE (P = 0.004) and lower ADAS-cog (P = 0.024); and lower PSQI (P < 0.001). CONCLUSION The multicomponent, nonpharmacological care program is associated with improved neuropsychiatric symptoms, anxiety, depression, quality of life, caregiver burden, cognitive function, and sleep quality in patients with mild AD experiencing anxiety and depression.

World Journal of PsychiatryVol. 16(11)
Good health and well-being
Dementia and Cognitive Impairment Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon